Ring A, Marx G, Steer C, Prendiville J, Ellis P
Department of Medical Oncology, Guy's Hospital, London, UK.
Int J Clin Pract. 2003 Jul-Aug;57(6):542-3.
This audit was designed to assess whether existing UK vaccination programmes mean that patients receiving chemotherapy are being vaccinated against influenza. One hundred and ten adult patients receiving chemotherapy at a south London tertiary referral centre were interviewed when they attended for their chemotherapy. Thirty-six of the 110 (33%) patients had received their influenza vaccination at the time of the study. Vaccination rates were significantly higher in those patients older than 65 years (53% vs 17%, p<0.001), and in those with co-morbidities (49% vs 25%, p<0.05). The vaccination rate in this at-risk population is lower than the overall national uptake in those aged 65 and over. Those patients most likely not to receive their influenza vaccination are those who have no indication for vaccination other than the fact they are receiving chemotherapy. Increased awareness of the benefits of influenza vaccine and its safety is needed among general practitioners, patients and oncologists.
本次审计旨在评估英国现有的疫苗接种计划是否意味着接受化疗的患者接种了流感疫苗。在伦敦南部一家三级转诊中心接受化疗的110名成年患者在接受化疗时接受了访谈。110名患者中有36名（33%）在研究期间接种了流感疫苗。65岁以上患者的接种率显著更高（53%对17%，p<0.001），有合并症的患者接种率也更高（49%对25%，p<0.05）。这一高危人群的疫苗接种率低于65岁及以上人群的全国总体接种率。最有可能未接种流感疫苗的患者是那些除了正在接受化疗外没有其他接种指征的患者。全科医生、患者和肿瘤学家需要提高对流感疫苗益处及其安全性的认识。
